ALPMY : Summary for ASTELLAS PHARMA INC - Yahoo Finance

U.S. Markets closed

Astellas Pharma Inc. (ALPMY)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
13.17-0.43 (-3.13%)
At close: 3:59PM EDT
People also watch
VIVHYTKPYYCFRUYEQCRYCEY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close13.60
Open13.21
Bid0.00 x
Ask0.00 x
Day's Range13.12 - 13.21
52 Week Range12.88 - 19.40
Volume82,016
Avg. Volume145,630
Market Cap25.81B
Beta0.43
PE Ratio (TTM)14.93
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.30 (2.16%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Astellas Announces Key Leadership Promotions in Development Organization
    PR Newswire15 hours ago

    Astellas Announces Key Leadership Promotions in Development Organization

    NORTHBROOK, Ill., April 28, 2017 /PRNewswire/ -- Astellas today announced three recent senior-level promotions within its Development organization. Joseph Fleishaker, Ph.D., FAAPS, FCP, was promoted to ...

  • Astellas Pharma, Inc. : ALPMY-US: Dividend Analysis : March 31st, 2017 (record date) : By the numbers : April 20, 2017
    Capital Cube9 days ago

    Astellas Pharma, Inc. : ALPMY-US: Dividend Analysis : March 31st, 2017 (record date) : By the numbers : April 20, 2017

    Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing Astellas Pharma, Inc. with the following peers – Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Amgen Inc. and Vical Incorporated (JNJ-US, MRK-US, PFE-US, AMGN-US and VICL-US). Astellas Pharma, Inc.’s dividend yield is 1.75 percent and its dividend payout is 28.51 percent. This compares ... Read more (Read more...)

  • Capital Cube23 days ago

    ETFs with exposure to Astellas Pharma, Inc. : April 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Astellas Pharma, Inc. Here are 5 ETFs with the largest exposure to ALPMY-US. Comparing the performance and risk of Astellas Pharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)